review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0962-8924(97)01214-2 |
P698 | PubMed publication ID | 9695814 |
P2093 | author name string | Prochiantz A | |
Chassaing G | |||
Derossi D | |||
P433 | issue | 2 | |
P304 | page(s) | 84-87 | |
P577 | publication date | 1998-02-01 | |
P1433 | published in | Trends in Cell Biology | Q1573994 |
P1476 | title | Trojan peptides: the penetratin system for intracellular delivery | |
P478 | volume | 8 |
Q40829469 | A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway. |
Q57281072 | A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth |
Q39811568 | A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers |
Q62603072 | A Versatile, Modular Platform for Multivalent Peptide Ligands Based on a Dendritic Wedge |
Q40260576 | A cell permeant peptide containing the cytoplasmic tail sequence of Fc receptor type IIA reduces calcium signaling and phagolysosome formation in neutrophils |
Q33220250 | A critical reassessment of penetratin translocation across lipid membranes |
Q40881286 | A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo |
Q73937790 | A new Antennapedia-derived vector for intracellular delivery of exogenous compounds |
Q64378631 | A peptide inhibitor of exportin1 blocks shuttling of the adenoviral E1B 55 kDa protein but not export of viral late mRNAs |
Q41952894 | ARF6 activated by the LHCG receptor through the cytohesin family of guanine nucleotide exchange factors mediates the receptor internalization and signaling. |
Q23920106 | Activation of targeted necrosis by a p53 peptide: a novel death pathway that circumvents apoptotic resistance |
Q28207026 | Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V |
Q24675650 | An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export |
Q38899655 | An unprecedented alteration in mode of action of IsCT resulting its translocation into bacterial cytoplasm and inhibition of macromolecular syntheses |
Q36325097 | Ankyrin binding mediates L1CAM interactions with static components of the cytoskeleton and inhibits retrograde movement of L1CAM on the cell surface |
Q47448961 | Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. |
Q36086779 | Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome |
Q24816124 | Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides |
Q40768103 | Antimicrobial and cell-penetrating peptides induce lipid vesicle fusion by folding and aggregation |
Q22248091 | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease |
Q40724163 | Application of cell adhesion to study signaling networks |
Q35058938 | Arginine containing peptides as delivery vectors. |
Q35039695 | Bacterial killing mechanism of sheep myeloid antimicrobial peptide-18 (SMAP-18) and its Trp-substituted analog with improved cell selectivity and reduced mammalian cell toxicity |
Q45075592 | Bimodal role of conventional protein kinase C in insulin secretion from rat pancreatic beta cells |
Q38357872 | Binding of cationic cell-permeable peptides to plastic and glass |
Q34343478 | BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies |
Q33306508 | BioShuttle-mediated plasmid transfer |
Q38957246 | Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease |
Q36492687 | Biological activity and biotechnological aspects of peptide nucleic acid. |
Q90041401 | Biophysical Insight on the Membrane Insertion of an Arginine-Rich Cell-Penetrating Peptide |
Q33901037 | Brain drug delivery technologies: novel approaches for transporting therapeutics |
Q40652159 | Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin. |
Q26830018 | Cationic membrane peptides: atomic-level insight of structure-activity relationships from solid-state NMR |
Q34365167 | Caveolae and the caveolins in human disease |
Q37514109 | Caveolin-1 provides palliation for adverse hepatic reactions in hypercholesterolemic rabbits |
Q37307795 | Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis |
Q26774462 | Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid |
Q37755594 | Cell penetrating elastin-like polypeptides for therapeutic peptide delivery |
Q34289086 | Cell penetrating peptide inhibitors of nuclear factor-kappa B. |
Q42739622 | Cell-penetrating HIV1 TAT peptides can generate pores in model membranes |
Q37140660 | Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease |
Q26801860 | Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery |
Q47097998 | Cell-penetrating peptides and their utility in genome function modifications (Review). |
Q30493854 | Cell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts |
Q33846582 | Cell-penetrating peptides. |
Q35058933 | Cellular delivery of peptide nucleic acid (PNA). |
Q74693781 | Cellular import mediated by nuclear localization signal Peptide sequences |
Q34460487 | Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation |
Q59419845 | Chapter 1 Piercing Lipid Bilayers with Peptides |
Q39773325 | Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope. |
Q40247472 | Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. |
Q57371915 | Chopper, a New Death Domain of the p75 Neurotrophin Receptor That Mediates Rapid Neuronal Cell Death |
Q36604251 | Cofilin peptide homologs interfere with immunological synapse formation and T cell activation |
Q34236236 | Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells |
Q73343301 | Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles |
Q44051673 | Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. |
Q74403380 | Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein-protein interaction |
Q51797571 | Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. |
Q44601156 | Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. |
Q33833348 | Cytoskeletal tumor suppressors that block oncogenic RAS signaling |
Q88630227 | Cytosolic delivery: Just passing through |
Q42400802 | D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue |
Q28485113 | DNA-interactive properties of crotamine, a cell-penetrating polypeptide and a potential drug carrier |
Q34280941 | Defined synthetic vaccines |
Q34709941 | Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O |
Q34067637 | Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce |
Q35082134 | Design strategies to improve soluble macromolecular delivery constructs |
Q42259278 | Designing mimics of membrane active proteins |
Q30493051 | Determination of penetratin secondary structure in live cells with Raman microscopy |
Q48782705 | Determination of tissue levels of a neuroprotectant drug: the cell permeable JNK inhibitor peptide |
Q42222936 | Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells |
Q38413685 | Development of protein mimics for intracellular delivery |
Q44565198 | Direct delivery of bacterial avirulence proteins into resistant Arabidopsis protoplasts leads to hypersensitive cell death |
Q33827217 | Discovery of DNA repair inhibitors by combinatorial library profiling |
Q27668096 | Discovery, structure-activity relationship studies, and crystal structure of nonpeptide inhibitors bound to the Shank3 PDZ domain |
Q33754862 | Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-activated potassium channel splice variant |
Q35058921 | Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities |
Q33963752 | Drug delivery to brain via the blood-brain barrier |
Q33853014 | Drug delivery to mitochondria: the key to mitochondrial medicine |
Q35013447 | Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting |
Q83357754 | Dynamics of transportan in bicelles is surface charge dependent |
Q46783831 | Effective penetration of cell-permeable peptide mimic of tyrosine residue 654 domain of beta-catenin into human renal tubular epithelial cells |
Q43419167 | Effects of the TAT peptide orientation and relative location on the protein transduction efficiency |
Q74190552 | Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate |
Q41998121 | Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticles. |
Q28396604 | Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules |
Q37957323 | Engineered biological entities for drug delivery and gene therapy protein nanoparticles. |
Q34237622 | Engineering persister-specific antibiotics with synergistic antimicrobial functions |
Q34479910 | Enhanced artemin/GFRα3 levels regulate mechanically insensitive, heat-sensitive C-fiber recruitment after axotomy and regeneration |
Q44056201 | Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin |
Q30844395 | Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase Ialpha |
Q34653969 | Functional characterization of nuclear localization and export signals in hepatitis C virus proteins and their role in the membranous web. |
Q93196602 | G-protein-coupled receptor 40 agonist GW9508 potentiates glucose-stimulated insulin secretion through activation of protein kinase Cα and ε in INS-1 cells |
Q34365725 | Generation of a selectively cytotoxic fusion protein against p53 mutated cancers |
Q34897833 | Getting into the brain: approaches to enhance brain drug delivery |
Q39973491 | Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies. |
Q34556390 | HIV-1 Tat vaccines |
Q35084374 | Heparan sulfate proteoglycan as a plasma membrane carrier |
Q35104353 | High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia |
Q31836174 | Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation |
Q40442150 | Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif |
Q33833393 | Homeodomain-derived peptides. In and out of the cells |
Q48224214 | How to navigate counter dogmatic research findings |
Q36674471 | Hsp70 chaperone as a survival factor in cell pathology |
Q35031980 | ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection |
Q49787719 | Identification and characterization of novel enhanced cell penetrating peptides for anti-cancer cargo delivery |
Q39700370 | Identification and molecular characterization of the RNA polymerase-binding motif of infectious bursal disease virus inner capsid protein VP3. |
Q34643412 | Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions |
Q77581166 | Identification of a signaling pathway activated specifically in the somatodendritic compartment by a heparan sulfate that regulates dendrite growth |
Q27939604 | Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway |
Q44507364 | Improvement of hepatocyte-specific gene expression by a targeted colchicine prodrug |
Q53234023 | In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. |
Q73266700 | In vitro transport and delivery of antisense oligonucleotides |
Q35127223 | In vivo imaging with oligonucleotides for diagnosis and drug development |
Q34348705 | Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells |
Q88628981 | Increased Expression of Transcription Factor SRY-box-Containing Gene 11 (Sox11) Enhances Neurite Growth by Regulating Neurotrophic Factor Responsiveness |
Q44090492 | Increased Hydrophobic Block Length of PTDMs Promotes Protein Internalization |
Q48867737 | Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier |
Q27653983 | Inhibition of Wnt signaling by Dishevelled PDZ peptides |
Q28202628 | Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects |
Q27865215 | Interactions between the L1 cell adhesion molecule and ezrin support traction-force generation and can be regulated by tyrosine phosphorylation. |
Q92900087 | Internalization mechanisms of cell-penetrating peptides |
Q26795943 | Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies |
Q37176400 | Intracellular delivery of nanoparticles via the HIV-1 tat peptide |
Q39304670 | Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin |
Q28592194 | Involvement of transportin 2-mediated HuR import in muscle cell differentiation |
Q33533840 | Light-activated proteins |
Q37271598 | Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor |
Q33647335 | Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231 |
Q21296784 | Mechanisms of cellular uptake of cell-penetrating peptides |
Q33683185 | Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines |
Q58717273 | Membrane Active Peptides and Their Biophysical Characterization |
Q40369050 | Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides |
Q39986995 | Membrane transducing activity of recombinant Hoxc8 protein and its possible application as a gene delivery vector |
Q33954498 | Messenger proteins: homeoproteins, TAT and others |
Q42122403 | Modulation of muscle contraction by a cell-permeable peptide |
Q38807254 | NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring |
Q30980242 | New phosphoramidite reagents for the synthesis of oligonucleotides containing a cysteine residue useful in peptide conjugation |
Q38661134 | New user-friendly approach to obtain an Eisenberg plot and its use as a practical tool in protein sequence analysis |
Q42800329 | Non-genetic modulation of Notch activity by artificial delivery of Notch intracellular domain into neural stem cells |
Q27303093 | Non-metabolic membrane tubulation and permeability induced by bioactive peptides |
Q90380886 | Non-viral transfection vectors: are hybrid materials the way forward? |
Q42584075 | Novel automated tracking analysis of particles subjected to shear flow: kindlin-3 role in B cells |
Q35200626 | Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy |
Q24555118 | Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs |
Q30841060 | Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. |
Q33998742 | On guanidinium and cellular uptake |
Q38348262 | PNA-DNA Chimeras Containing 5-Alkynyl-pyrimidine PNA Units. Synthesis, Binding Properties, and Enzymatic Stability |
Q41816894 | Passage of cell-penetrating peptides across a human epithelial cell layer in vitro |
Q48678243 | Penetratin peptide potentiates endogenous calcium-activated chloride currents in Xenopus oocytes |
Q40317625 | Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. |
Q33754501 | Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides |
Q37572760 | Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics. |
Q36780055 | Peptide-guided gene delivery |
Q45731678 | Peptides containing membrane-transiting motifs inhibit virus entry |
Q23918117 | Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells |
Q33203531 | Phage display-derived peptides as therapeutic alternatives to antibodies |
Q34180629 | Plasmon-waveguide resonance and impedance spectroscopy studies of the interaction between penetratin and supported lipid bilayer membranes |
Q40768223 | Possible existence of common internalization mechanisms among arginine-rich peptides |
Q34160291 | Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides |
Q89805468 | Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement |
Q34804863 | Prospects for cationic polymers in gene and oligonucleotide therapy against cancer |
Q33845365 | Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity |
Q92943482 | Protein Transduction Domain Mimic (PTDM) Self-Assembly? |
Q35136309 | Protein transduction domains: are they delivering? |
Q33905945 | Protein transduction: unrestricted delivery into all cells? |
Q37597161 | RNA interference technologies and therapeutics: from basic research to products |
Q40868090 | Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E. |
Q30980249 | Rapid routes of synthesis of oligonucleotide conjugates from non-protected oligonucleotides and ligands possessing different nucleophilic or electrophilic functional groups |
Q30175250 | Rational development of cell-penetrating high affinity SH3 domain binding peptides that selectively disrupt the signal transduction of Crk family adapters. Amgen Peptide Technology Group |
Q42978427 | Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery |
Q40468941 | Recognition of phosphorylated-Smad2-containing complexes by a novel Smad interaction motif |
Q36703495 | Regulation of survival in adult hippocampal and glioblastoma stem cell lineages by the homeodomain-only protein HOP |
Q34018908 | Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study. |
Q42027873 | Requirement of different mitochondrial targeting sequences of the yeast mitochondrial transcription factor Mtf1p when synthesized in alternative translation systems |
Q24292189 | SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) |
Q41782961 | SPPS resins impact the PNA-syntheses' improvement |
Q39455728 | SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. |
Q30433235 | SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway |
Q37389347 | Signaling with homeoprotein transcription factors in development and throughout adulthood |
Q27024724 | Solution NMR studies on the orientation of membrane-bound peptides and proteins by paramagnetic probes |
Q39897284 | Sox11 transcription factor modulates peripheral nerve regeneration in adult mice |
Q42509467 | Specific inhibition of interleukin-4-dependent Stat6 activation by an intracellularly delivered peptide |
Q34076012 | Strategies for manipulating the p53 pathway in the treatment of human cancer. |
Q31152345 | Structure-function relationship of new crotamine isoform from the Crotalus durissus cascavella |
Q40315427 | Suppression of gene expression by a cell-permeable Tet repressor |
Q59103173 | Synthetic Crossfeeding Cocultures in Yeast: Computational Model of Autoregulation and Design of a Tryptophan Export Device |
Q44129457 | Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ |
Q43936911 | TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells |
Q44141063 | Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery |
Q34264476 | Targeting large molecules to mitochondria |
Q40727821 | Targeting peptides for microglia identified via phage display |
Q44624372 | Targeting proteins to mitochondria using TAT. |
Q40579166 | The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo |
Q42468094 | The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction |
Q37278005 | The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters |
Q40000803 | The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides |
Q35904667 | The many ways to cross the plasma membrane. |
Q48874069 | The neuronal microtubule-associated protein 1B is under homeoprotein transcriptional control. |
Q30414687 | The quiet renaissance of protein nuclear magnetic resonance. |
Q45208898 | The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach |
Q24605482 | The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH |
Q24794932 | The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway |
Q44915295 | Transactivator of transcription fusion protein transduction causes membrane inversion |
Q34384351 | Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas |
Q40773148 | Translocation activity of C-terminal domain of pestivirus Erns and ribotoxin L3 loop |
Q64075816 | Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo |
Q38510992 | Transporter molecules influence the gene expression in HeLa cells |
Q33940327 | Truncation, randomization, and selection: generation of a reduced length c-Jun antagonist that retains high interaction stability |
Q33959727 | Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes |
Q35978545 | Tumor penetrating peptides for improved drug delivery |
Q39690631 | Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain |
Q83939141 | Use of a penetratin-linked peptide in Dictyostelium |
Q34123245 | Vectorial delivery of macromolecules into cells using peptide-based vehicles |
Q62659987 | What Can Pleiotropic Proteins in Innate Immunity Teach Us about Bioconjugation and Molecular Design? |
Q40683524 | beta-Homolysine oligomers: a new class of Trojan carriers |
Search more.